Keraring Global Users Group Meeting · London, 13 September 2026 Alberto Bellone, MD, Ophthalmic Surgeon, Turin, Italy On 13 September I took part, as a panel member, in the Keraring Global Users Group Meeting in London, held at the Shangri-La The Shard. It is the international meeting devoted to the surgical treatment of keratoconus with...Read More

For diseases that involve thinning of the cornea (such as keratoconus, for example, a not widely known eye disease that results in vision loss for many people), transplant-based surgeries are currently the most sought-after solution. Worldwide, tens of millions of people are affected by cornea diseases, but only a small proportion are fortunate enough to...Read More

A study into the link between extracellular vesicles (EVs) in tears and keratoconus revealed potential pathways to new causes and treatment. Researchers at the North Texas Eye Research Institute identified, isolated and characterised tear extracellular vesicles in keratoconus subjects and found that they have a distinct phenotype compared to their healthy counterparts. In the study, 10...Read More

Keratoconus is a corneal disease characterized by progressive thinning of the cornea and swelling of the corneal structure; if this progression is not stopped, it leads to the development of myopia and irregular astigmatism, resulting in impaired quality of vision and visual acuity. About this disease, through the National Eye Institute Visual Functioning Questionnaire-25, the...Read More

Corneal transplants have always been performed with human tissue taken, after death, from organ donors. But tissue for the corneal transplants has always been in short supply compared to the number of patients requiring it, so this situation has prompted researchers to look for a suitable, safe, effective and permanent solution. And here are the...Read More